Febrile ulceronecrotic Mucha–Habermann disease following suspected hemorrhagic chickenpox infection in a 20-month-old boy
- 186 Downloads
- 2 Citations
Abstract
We present the youngest pediatric patient so far with febrile ulcerative Mucha–Haberman disease (FUMHD) after an admitting clinical picture of hemorrhagic varicella infection. With a time to diagnosis of 25 days, the 20-month-old boy responded to low dose cyclosporine and prednisolone given for 3 months and is free of disease after 4 years of follow up. We describe a polyclonal CD8+ T cell response with elevated pro-inflammatory cytokines and a fivefold upregulation of the high-affinity Fc receptor type I (CD64) on granulocytes. Early consideration of FUMHD in the differential diagnosis of a systemic inflammatory disease combined with a generalized necrotizing rash is important for early and adequate management of children with this rare and challenging disease.
Keywords
Mean Fluorescence Intensity Systemic Inflammatory Disease Varicella Infection Brivudin Vesicular RashNotes
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
References
- 1.Tilly JJ, Drolet BA, Esterly NB. Lichenoid eruptions in children. J Am Acad Dermatol. 2004;51:606–24.CrossRefPubMedGoogle Scholar
- 2.Lambert WC, Everett MA. The nosology of parapsoriasis. J Am Acad Dermatol. 1981;5:373–95.CrossRefPubMedGoogle Scholar
- 3.Patel DG, Kihiczak G, Schwartz RA, Janniger CK, Lambert WC. Pityriasis lichenoides. Cutis. 2000;65(17–20):23.Google Scholar
- 4.Bowers S, Warshaw EM. Pityriasis lichenoides and its subtypes. J Am Acad Dermatol. 2006;55:557–72.CrossRefPubMedGoogle Scholar
- 5.Rosman IS, Liang LC, Patil S, Bayliss SJ, White AJ. Febrile ulceronecrotic Mucha–Habermann disease with central nervous system vasculitis. Pediatr Dermatol. 2013;30:90–3.CrossRefPubMedGoogle Scholar
- 6.Miyamoto T, Takayama N, Kitada S, Hagari Y, Mihara M. Febrile ulceronecrotic Mucha–Habermann disease: a case report and a review of the literature. J Clin Pathol. 2003;56:795–7.PubMedCentralCrossRefPubMedGoogle Scholar
- 7.Yamada K, Motegi S, Matsushima Y. Febrile ulceronecrotic Mucha–Habermann disease in a young boy: a case report and review of the literature. Acta Derm Venereol. 2014;94:603–4.CrossRefPubMedGoogle Scholar
- 8.Kaufman WS, McNamara EK, Curtis AR, Kosari P, Jorizzo JL, Krowchuk DP. Febrile ulceronecrotic Mucha–Habermann disease (pityriasis lichenoides et varioliformis acuta fulminans) presenting as Stevens–Johnson syndrome. Pediatr Dermatol. 2012;29:135–40.CrossRefPubMedGoogle Scholar
- 9.Kim HS, Yu DS, Kim JW. A case of febrile ulceronecrotic Mucha–Habermann’s disease successfully treated with oral cyclosporin. J Eur Acad Dermatol Venereol. 2007;21:272–3.PubMedGoogle Scholar
- 10.Gunatheesan S, Ferguson J, Moosa Y. Pityriasis lichenoides et varioliformis acuta: a rare association with the measles, mumps and rubella vaccine. Australas J Dermatol. 2012;53:e76–8.CrossRefPubMedGoogle Scholar
- 11.Meziane L, Caudron A, Dhaille F, Jourdan M, Dadban A, Lok C, Chaby G. Febrile ulceronecrotic Mucha–Habermann disease: treatment with infliximab and intravenous immunoglobulins and review of the literature. Dermatology. 2012;225:344–8.CrossRefPubMedGoogle Scholar
- 12.Berti E, Tomasini D, Vermeer MH, Meijer CJ, Alessi E, Willemze R. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior. Am J Pathol. 1999;155:483–92.PubMedCentralCrossRefPubMedGoogle Scholar
- 13.Weinberg JM, Kristal L, Chooback L, Honig PJ, Kramer EM, Lessin SR. The clonal nature of pityriasis lichenoides. Arch Dermatol. 2002;138:1063–7.CrossRefPubMedGoogle Scholar
- 14.Dereure O, Levi E, Kadin ME. T-Cell clonality in pityriasis lichenoides et varioliformis acuta: a heteroduplex analysis of 20 cases. Arch Dermatol. 2000;136:1483–6.CrossRefPubMedGoogle Scholar
- 15.Tsianakas A, Hoeger PH. Transition of pityriasis lichenoides et varioliformis acuta to febrile ulceronecrotic Mucha–Habermann disease is associated with elevated serum tumour necrosis factor-alpha. Br J Dermatol. 2005;152:794–9.CrossRefPubMedGoogle Scholar
- 16.Elawady S, Botros SK, Sorour AE, Ghany EA, Elbatran G, Ali R. Neutrophil CD64 as a diagnostic marker of sepsis in neonates. J Investig Med. 2014;62:644–9.PubMedGoogle Scholar
- 17.Li S, Huang X, Chen Z, Zhong H, Peng Q, Deng Y, Qin X, Zhao J. Neutrophil CD64 expression as a biomarker in the early diagnosis of bacterial infection: a meta-analysis. Int J Infect Dis. 2013;17:e12–23.CrossRefPubMedGoogle Scholar
- 18.Lynema S, Marmer D, Hall ES, Meinzen-Derr J, Kingma PS. Neutrophil CD64 as a diagnostic marker of sepsis: impact on neonatal care. Am J Perinatol. 2014. doi: 10.1055/s-0034-1384644.
- 19.Abdel-Salam BK, Ebaid H. Upregulation of major histocompatibility complex class II, CD83, CD64, and CD14 on polymorphonuclear neutrophils stimulated with interleukin-15. J Microbiol Immunol Infect. 2008;41:462–8.PubMedGoogle Scholar
- 20.Quayle JA, Watson F, Bucknall RC, Edwards SW. Neutrophils from the synovial fluid of patients with rheumatoid arthritis express the high affinity immunoglobulin G receptor, Fc gamma RI (CD64): role of immune complexes and cytokines in induction of receptor expression. Immunology. 1997;91:266–73.PubMedCentralCrossRefPubMedGoogle Scholar